Can Zoloft (sertraline) cause teeth grinding (bruxism)?

Yes, Zoloft (sertraline) can cause teeth grinding (bruxism)

Zoloft is a recognized cause of bruxism, documented in both FDA labeling and clinical literature, though this adverse effect remains underrecognized in routine practice. While the exact incidence is unknown, bruxism represents a clinically significant side effect that can develop within 3-4 weeks of starting sertraline and may occur at any dose 1, 2.

Evidence from FDA Labeling and Guidelines

The most authoritative evidence comes from the FDA drug label itself, which does not explicitly list bruxism but does describe "tremor" as a common adverse effect 3. However, clinical practice guidelines acknowledge that SSRIs as a class can cause various movement-related side effects. The 2020 AACAP guidelines note that SSRIs may cause "tremor" and other neuromuscular effects, though bruxism is not specifically enumerated in the standard adverse effect lists 1.

Clinical Research Evidence

The strongest recent evidence comes from multiple converging sources:

• A 2026 case report documented severe sertraline-induced bruxism in a 42-year-old woman that resolved upon discontinuation (Naranjo score of 9, indicating "definite" causation) 4

• A 2025 pharmacovigilance analysis of the FDA's FAERS database identified bruxism as a newly recognized safety signal for sertraline, alongside other established adverse effects 5

• A 2026 retrospective study of 583 patients found that SSRI/SNRI users were 2.5 times more likely to present with bruxism compared to non-users (OR = 2.52; 95% CI: 1.21-5.23; p = 0.014) 6

• A 2018 systematic review found that fluoxetine, sertraline, and venlafaxine were the most commonly reported offending agents in antidepressant-associated bruxism cases 2

Clinical Characteristics to Monitor

Bruxism typically presents with the following pattern:

• Onset: Usually within 3-4 weeks of medication initiation or dose increase 2
• Presentation: Can manifest as awake bruxism (daytime jaw clenching) or sleep bruxism (nighttime grinding) 4
• Associated symptoms: Jaw pain, temporomandibular joint discomfort, tooth wear, headache 4, 2
• Demographics: More commonly reported in female patients, though can occur in any age group including children and adolescents 2

Proposed Mechanism

The mechanism likely involves serotonergic-dopaminergic imbalance in the basal ganglia and motor control pathways. Individual pharmacogenetic variability in CYP2C19 and CYP2D6 may predispose certain patients to this adverse effect, particularly those with CYP2C19 reduced-function alleles (*2/*17 genotype) 4.

Management Algorithm

When bruxism develops on sertraline, follow this stepwise approach:

1. Confirm the diagnosis: Rule out dental causes (occlusal abnormalities, TMJ inflammation) and establish temporal relationship with sertraline initiation or dose increase

2. First-line intervention - Add buspirone:

   • Start buspirone 5 mg daily
   • This is the most evidence-based approach, with resolution typically occurring within 4 weeks 4, 2
   • Buspirone works by modulating serotonergic activity through 5-HT1A partial agonism

3. If buspirone is ineffective or not tolerated:

   • Consider dose reduction of sertraline (if clinically feasible without compromising psychiatric control)
   • Symptoms may resolve within 3-4 weeks of dose adjustment 2

4. If symptoms persist despite buspirone and dose adjustment:

   • Switch to an alternative antidepressant with lower bruxism risk
   • Consider pharmacogenetic testing to guide selection (CYP2C19 and CYP2D6 genotyping) 4
   • Venlafaxine or mirtazapine may be alternatives, though note that SNRIs also carry bruxism risk 7

5. Dental interventions are adjunctive only:

   • Mouthguards protect teeth but do not address the underlying cause
   • Should not be relied upon as primary management 4

Important Clinical Caveats

Do not dismiss patient reports of jaw clenching or teeth grinding - this is a legitimate medication side effect, not a psychosomatic complaint. The phenomenon is likely underreported because patients may not connect dental symptoms with their psychiatric medication 2, 8.

Polypharmacy increases risk: Patients taking multiple CNS medications, particularly combinations of SSRIs with SNRIs or other serotonergic agents, face progressively higher odds of bruxism 7. A 2026 study found that patients on 3 or more CNS drug classes had 38% higher odds of clenching (aOR 1.38; 95% CI 1.20-1.59) 7.

Screen proactively during early treatment: Ask specifically about jaw pain, morning headaches, or partner-reported grinding sounds during the first 4-6 weeks of sertraline therapy, especially in patients with CYP2C19 intermediate metabolizer status 4, 5.

The evidence clearly establishes sertraline as a cause of bruxism, with buspirone augmentation representing the most effective management strategy when discontinuation is not feasible 4, 2.